Lupine share price: Lupine share up 0.57% as Sensex falls
Earlier today, the title saw a gap at the start of the session. The stock listed a 52-week high of Rs 1,267.5 and a 52-week low of Rs 856.0 on NSE. About 68,321 shares changed hands at the box office until 10:31 a.m. (IST).
The action opened at Rs 962.0 and hit an intraday high and low of Rs 975.75 and Rs 959.75 during the session so far. The script cited a price-to-earnings (PE) ratio of 26.59, earnings per share (EPS) of Rs 36.4, and price-to-book (PB) of 3.36, while return on equity ( ROE) amounted to Rs 8.93.
Promoter / FII Holding
The promoters held 46.84% of the company’s capital as of October 12, while the holdings of FII and MF amounted to 18.6% and 11.43% respectively.
Key financial data
With a market capitalization of Rs 43,924.17 crore, the company operates in the pharmaceutical sector – Indian. For the quarter ended June 30, 2021, the company reported consolidated sales of Rs 4,298.02 crore, up 11.89% from the previous quarter at Rs 3,841.32 crore and up 20.35% compared to the same quarter a year ago. The company reported net profit of Rs 542.46 crore for the most recent quarter, up 407.45 percent from the corresponding quarter of last year.
The Relative Strength Index (RSI) for the stock stands at 50.55. The RSI hovers between zero and 100. Traditionally it is considered an overbought condition when the value of the RSI is above 70 and an oversold condition when it is below 30. Analysts say the RSI indicator should only not be viewed in isolation, as it may not be sufficient to take a trade call, in the same way that a fundamental analyst cannot give a ‘buy’ or ‘sell’ recommendation using a single valuation ratio .